lobbying_activities: 2827294

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2827294	fdff7e33-b7f3-4cec-978d-5c58fe0476e7	Q2	TRAVERE THERAPEUTICS	401104190	TRAVERE THERAPEUTICS	2022	second_quarter	PHA	H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act and related Senate legislation. H.R. 19, Lower Costs More Cures Act. Legislative proposals regarding drug pricing, value, and reimbursement in H.R. 5736 Build Back Better Act and related Senate legislation. H.R. 7667, the Food and Drug Amendments of 2022 and related Senate legislation.	HOUSE OF REPRESENTATIVES,SENATE		290000	0	0	2022-07-19T07:59:16-04:00